Los Angeles Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $551K | Buy |
266,128
+198,325
| +293% | +$411K | ﹤0.01% | 829 |
|
|
2025
Q1 | $149K | Buy |
67,803
+150
| +0.2% | +$330 | ﹤0.01% | 1056 |
|
|
2024
Q4 | $104K | Sell |
67,653
-153,181
| -69% | -$234K | ﹤0.01% | 1085 |
|
|
2024
Q3 | $439K | Sell |
220,834
-18,065
| -8% | -$35.9K | ﹤0.01% | 897 |
|
|
2024
Q2 | $836K | Sell |
238,899
-254,365
| -52% | -$890K | ﹤0.01% | 713 |
|
|
2024
Q1 | $1.37M | Sell |
493,264
-21,113
| -4% | -$58.5K | ﹤0.01% | 591 |
|
|
2023
Q4 | $874K | Buy |
514,377
+171,250
| +50% | +$291K | ﹤0.01% | 719 |
|
|
2023
Q3 | $353K | Buy |
343,127
+3,653
| +1% | +$3.76K | ﹤0.01% | 917 |
|
|
2023
Q2 | $394K | Sell |
339,474
-366,203
| -52% | -$425K | ﹤0.01% | 929 |
|
|
2023
Q1 | $1.07M | Buy |
705,677
+538,024
| +321% | +$812K | ﹤0.01% | 649 |
|
|
2022
Q4 | $419K | Sell |
167,653
-5,400
| -3% | -$13.5K | ﹤0.01% | 937 |
|
|
2022
Q3 | $730K | Buy |
+173,053
| New | +$730K | ﹤0.01% | 805 |
|
|
2021
Q2 | – | Sell |
-15,940
| Closed | -$258K | – | 1602 |
|
|
2021
Q1 | $258K | Sell |
15,940
-9,710
| -38% | -$157K | ﹤0.01% | 1473 |
|
|
2020
Q4 | $543K | Sell |
25,650
-50
| -0.2% | -$1.06K | ﹤0.01% | 1177 |
|
|
2020
Q3 | $381K | Buy |
25,700
+1,230
| +5% | +$18.2K | ﹤0.01% | 1192 |
|
|
2020
Q2 | $360K | Buy |
24,470
+9,276
| +61% | +$136K | ﹤0.01% | 1232 |
|
|
2020
Q1 | $178K | Buy |
+15,194
| New | +$178K | ﹤0.01% | 1203 |
|
|
2019
Q2 | – | Sell |
-14,890
| Closed | -$364K | – | 1377 |
|
|
2019
Q1 | $364K | Sell |
14,890
-4,800
| -24% | -$117K | ﹤0.01% | 1158 |
|
|
2018
Q4 | $511K | Buy |
19,690
+11,640
| +145% | +$302K | ﹤0.01% | 958 |
|
|
2018
Q3 | $255K | Buy |
+8,050
| New | +$255K | ﹤0.01% | 1272 |
|